IGF1R and lung carcinoma: For instance, genetic silencing of FURIN inhibits processing of the insulin-like growth factor 1 receptor (IGF1R), migration, and invasion in lung cancers, which indicates that furin is a potential therapeutic target in lung cancers (Mbikay et al., 1997; Bassi et al., 2017).